SNG Hawk’s Nest is Back!
MaRS Discovery District
November 21, 2019
6 pm – 10 pm
IT STARTS WITH DOZENS OF STARTUPS
Toronto’s medtech scene is BOOMING! Across the city’s incubators, we screen and interview dozens of pitch applications from the city’s most promising emerging medtech companies.
FOUR WILL BE SELECTED TO PITCH
Our 4 most promising applicants are invited to pitch their companies live on November 21 in front of our all-star panel of “Hawks” and a 300+ person audience.
THE AUDIENCE SELECTS ONE CHAMPION
The winning company will leave the event with a NON-DILUTIVE CHEQUE for 50% of the event’s net proceeds (up to a maximum of $50,000), with all remaining proceeds being donated to the Sunnybrook Medventions Program!
Hawk’s Nest Highlights Thus Far
- 80+ applicants screened
- 40 corporate sponsorships/partnerships received
- More than 600 in attendance
- Press coverage in the National Post, University of Toronto Press, Toronto Sun, & BetaKit
- More than $175,000 raised
- With unencumbered cheques total more than $60,000 awarded to winners.
- Unanimously positive feedback received from attendees, contestants, judges, and volunteers
The 2018 Champion: Mimosa Diagnostics
The 2017 Champion: Trexo Robotics
Tréxō Robotics is building the first exoskeleton device designed specifically for children with disabilities. Tréxō’s unique design allows it to convert any passive walker into a fully powered exoskeleton device that can be used anywhere, at any time, at a fraction of the price of currently available competitor devices. Founded in 2016 by two University of Waterloo engineering graduates, Tréxō is driven by the belief that people shouldn’t be constrained to a wheelchair, and is on a mission to redefine mobility solutions for all.
The 2018 Finalists
The 2017 Finalists
People’s own cells and genomes will become the foundation of future biomedical therapeutics. Aged cells, however, are highly mutated, deteriorated versions of our current cells. Acorn Biolabs has developed a mail-in non-invasive cell collection kit to cryopreserve and sequence people’s cells, empowering them with information today and preparing them for future therapeutics.
At RetiSpec, we are developing a non-invasive retinal scanner that detects Alzheimer’s pathology years before the onset of symptoms. Our technology aims to help pharmaceutical companies optimize expensive patient screening processes for Alzheimer’s-related clinical trials and more importantly, help clinicians diagnose and treat Alzheimer’s at earlier stages of onset, when patients are typically much more responsive to intervening therapeutics and other forms of treatment.
VivaVax creates biosafe formulations that protect sensitive medications from breaking down during transport & storage. We offer better temperature resistance with a 2-3X spoilage improvement over current technologies.
To take the lead in addressing this domestic skills gap, Sunnybrook launched its flagship Medventions program, which provides scientists, clinicians and engineers alike with a streamlined entrepreneurial training approach focused on nurturing local medtech expertise.
Medventions’ dual mandate is to both pave the way for new generations of medtech-gadgets that directly target unmet clinical needs and mentor its participants in the complexities of bringing their innovations from bench to bedside. Key components of the program include innovation internships, a bi-weekly medtech innovation seminar, an annual innovation symposium, and an online medtech community portal.
Medventions’ ultimate goal is to enable both patients and the Canadian health care system as a whole to reap the benefits of the medical inventions that emerge from its program, and it is with programs such as Medventions that Sunnybrook will ultimately realize its goal of inventing the future of healthcare.
Hawk’s Nest is brought to you by Sunnybrook Next Generation (SNG). SNG is a group of young professional volunteer advocates and ambassadors that supports the mission and goals of Sunnybrook by engaging a new generation of supporters through awareness initiatives, fundraising activities, and active participation in the community of Sunnybrook.
SNG has built and continues to build a strong core group of volunteer leaders who are passionate about Sunnybrook and healthcare in general. Through its social calendar, SNG provides professional and social networking opportunities to its membership and the young professional community at large while raising funds for the hospital’s highest priority needs.
Dear Friend of Sunnybrook,
On behalf of SNG, welcome! Your interest in our mission and goals is what fuels us to support Sunnybrook’s highest priority needs.
Since 2014, SNG has consistently demonstrated itself as an organization capable of achieving tremendous success across a wide range of fundraising, community engagement and educational outreach initiatives. With the collective efforts of our executive, committees and general members, we strive to educate the next generation of Sunnybrook’s community leaders, while raising critical funds to help Sunnybrook remain at the forefront of medical innovation – both now and for decades to come.
The success of Hawk’s Nest has helped accelerate the growth of SNG in a big way and has generated tremendous publicity for both Sunnybrook as a whole and the incredible finalists who have pitched at our event.
While we have been thrilled by the success of our first two Hawk’s Nest events, we believe that we still have ample room and opportunity to grow our franchise. Our vision is to make Hawk’s Nest THE premier startup pitch competition in Canada, and to achieve that goal we will need many more sponsors, media partners, volunteers, and high profile attendees alike.
Your support of Hawk’s Nest means the world to us and with your help, we look forward to taking Hawk’s Nest to even greater heights this year. We hope you will consider supporting our event and please join us on November 21st for a night of fun and inspiration!
Jesse Buckstein & David Tile
Co-Chairs, SNG Hawk’s Nest
Principal, CPOINT Capital
Founder, Nimble Media